» Articles » PMID: 31976201

Internalization Mechanisms of Cell-penetrating Peptides

Overview
Specialty Biotechnology
Date 2020 Jan 25
PMID 31976201
Citations 153
Authors
Affiliations
Soon will be listed here.
Abstract

In today's modern era of medicine, macromolecular compounds such as proteins, peptides and nucleic acids are dethroning small molecules as leading therapeutics. Given their immense potential, they are highly sought after. However, their application is limited mostly due to their poor in vivo stability, limited cellular uptake and insufficient target specificity. Cell-penetrating peptides (CPPs) represent a major breakthrough for the transport of macromolecules. They have been shown to successfully deliver proteins, peptides, siRNAs and pDNA in different cell types. In general, CPPs are basic peptides with a positive charge at physiological pH. They are able to translocate membranes and gain entry to the cell interior. Nevertheless, the mechanism they use to enter cells still remains an unsolved piece of the puzzle. Endocytosis and direct penetration have been suggested as the two major mechanisms used for internalization, however, it is not all black and white in the nanoworld. Studies have shown that several CPPs are able to induce and shift between different uptake mechanisms depending on their concentration, cargo or the cell line used. This review will focus on the major internalization pathways CPPs exploit, their characteristics and regulation, as well as some of the factors that influence the cellular uptake mechanism.

Citing Articles

Peptides: potential delivery systems for mRNA.

Liang H, Xing Y, Wang K, Zhang Y, Yin F, Li Z RSC Chem Biol. 2025; .

PMID: 40071030 PMC: 11891934. DOI: 10.1039/d4cb00295d.


Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines.

Xiao W, Jiang W, Chen Z, Huang Y, Mao J, Zheng W Signal Transduct Target Ther. 2025; 10(1):74.

PMID: 40038239 PMC: 11880366. DOI: 10.1038/s41392-024-02107-5.


Cell-penetrating peptide-grafted AAV2 capsids for improved retinal delivery via intravitreal injection.

Wang J, Cui M, Liu H, Guo P, McGowan J, Cheng S Mol Ther Methods Clin Dev. 2025; 33(1):101426.

PMID: 40027263 PMC: 11872077. DOI: 10.1016/j.omtm.2025.101426.


Dual-Labeled Small Peptides in Cancer Imaging and Fluorescence-Guided Surgery: Progress and Future Perspectives.

Minges P, Eder M, Eder A Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40005958 PMC: 11858487. DOI: 10.3390/ph18020143.


FDA-Approved Antibacterials and Echinocandins.

Al Musaimi O Antibiotics (Basel). 2025; 14(2).

PMID: 40001410 PMC: 11851826. DOI: 10.3390/antibiotics14020166.


References
1.
Futaki S, Nakase I . Cell-Surface Interactions on Arginine-Rich Cell-Penetrating Peptides Allow for Multiplex Modes of Internalization. Acc Chem Res. 2017; 50(10):2449-2456. DOI: 10.1021/acs.accounts.7b00221. View

2.
Ruczynski J, Wierzbicki P, Kogut-Wierzbicka M, Mucha P, Siedlecka-Kroplewska K, Rekowski P . Cell-penetrating peptides as a promising tool for delivery of various molecules into the cells. Folia Histochem Cytobiol. 2014; 52(4):257-69. DOI: 10.5603/FHC.a2014.0034. View

3.
Kawaguchi Y, Takeuchi T, Kuwata K, Chiba J, Hatanaka Y, Nakase I . Syndecan-4 Is a Receptor for Clathrin-Mediated Endocytosis of Arginine-Rich Cell-Penetrating Peptides. Bioconjug Chem. 2016; 27(4):1119-30. DOI: 10.1021/acs.bioconjchem.6b00082. View

4.
Meade B, Dowdy S . Enhancing the cellular uptake of siRNA duplexes following noncovalent packaging with protein transduction domain peptides. Adv Drug Deliv Rev. 2007; 60(4-5):530-6. PMC: 2293332. DOI: 10.1016/j.addr.2007.10.004. View

5.
Damm E, Pelkmans L, Kartenbeck J, Mezzacasa A, Kurzchalia T, Helenius A . Clathrin- and caveolin-1-independent endocytosis: entry of simian virus 40 into cells devoid of caveolae. J Cell Biol. 2005; 168(3):477-88. PMC: 2171728. DOI: 10.1083/jcb.200407113. View